| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Neuronetics Inc (NASDAQ: STIM)
STIM Technical Analysis
5
| As on 9th Jun 2023 STIM STOCK Price closed @ 2.37 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.43 & Strong Sell for SHORT-TERM with Stoploss of 3.66 we also expect STOCK to react on Following IMPORTANT LEVELS. |
STIMSTOCK Price
| Open | 2.43 | Change | Price | % |
| High | 2.49 | 1 Day | -0.05 | -2.07 |
| Low | 2.37 | 1 Week | -0.55 | -18.84 |
| Close | 2.37 | 1 Month | 0.14 | 6.28 |
| Volume | 109952 | 1 Year | -1.96 | -45.27 |
| 52 Week High 6.87 | 52 Week Low 2.07 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| STIM Daily Charts |
STIM Intraday Charts |
Whats New @ Bazaartrend |
STIM Free Analysis |
|
|
STIM Important Levels Intraday
| RESISTANCE | 2.60 |
| RESISTANCE | 2.53 |
| RESISTANCE | 2.48 |
| RESISTANCE | 2.44 |
| SUPPORT | 2.30 |
| SUPPORT | 2.26 |
| SUPPORT | 2.21 |
| SUPPORT | 2.14 |
STIM Forecast May 2024
| 4th UP Forecast | 5.24 |
| 3rd UP Forecast | 4.32 |
| 2nd UP Forecast | 3.75 |
| 1st UP Forecast | 3.18 |
| 1st DOWN Forecast | 1.56 |
| 2nd DOWN Forecast | 0.99 |
| 3rd DOWN Forecast | 0.42 |
| 4th DOWN Forecast | -0.5 |
STIM Weekly Forecast
| 4th UP Forecast | 3.66 |
| 3rd UP Forecast | 3.25 |
| 2nd UP Forecast | 2.99 |
| 1st UP Forecast | 2.74 |
| 1st DOWN Forecast | 2.00 |
| 2nd DOWN Forecast | 1.75 |
| 3rd DOWN Forecast | 1.49 |
| 4th DOWN Forecast | 1.08 |
STIM Forecast2024
| 4th UP Forecast | 11.95 |
| 3rd UP Forecast | 8.88 |
| 2nd UP Forecast | 6.98 |
| 1st UP Forecast | 5.08 |
| 1st DOWN Forecast | -0.34 |
| 2nd DOWN Forecast | -2.24 |
| 3rd DOWN Forecast | -4.14 |
| 4th DOWN Forecast | -7.21 |
Neuronetics Inc ( NASDAQ USA Symbol : STIM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
STIM Business Profile
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2003 and is headquartered in Malvern, Pennsylvania. Address: 3222 Phoenixville Pike, Malvern, PA, United States, 19355
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service